05/10/2024 | Press release | Distributed by Public on 05/10/2024 15:02
|
Delaware
(State or other jurisdiction of
incorporation or organization) |
| |
27-4412575
(IRS Employer
Identification Number) |
|
|
Large accelerated filer ☐
|
| |
Accelerated filer ☐
|
| |
Non-accelerated filer ☒
|
| |
Smaller reporting company ☒
|
|
| | | | | | | | | |
Emerging growth company ☐
|
|
| | |
Page
|
| |||
ABOUT THIS PROSPECTUS
|
| | | | 1 | | |
PROSPECTUS SUMMARY
|
| | | | 2 | | |
THE OFFERING
|
| | | | 3 | | |
RISK FACTORS
|
| | | | 4 | | |
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
| | | | 5 | | |
USE OF PROCEEDS
|
| | | | 6 | | |
SELLING STOCKHOLDERS
|
| | | | 6 | | |
PLAN OF DISTRIBUTION
|
| | | | 11 | | |
LEGAL MATTERS
|
| | | | 13 | | |
EXPERTS
|
| | | | 13 | | |
WHERE YOU CAN FIND MORE INFORMATION
|
| | | | 13 | | |
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE
|
| | | | 14 | | |
| | |
Shares of Common Stock
Beneficially Owned Prior to the Offering |
| |
Maximum Number
of Shares to be Sold Pursuant to this Prospectus(1) |
| |
Shares of Common Stock
Beneficially Owned After the Offering |
| |||||||||||||||||||||
Name and Address of Selling Stockholder(2)
|
| |
Number
|
| |
Percent
(%) |
| |
Number
|
| |
Number
|
| |
Percent
(%) |
| |||||||||||||||
Entities Affiliated with Rock Springs Capital Management LP(3) 650 S. Exeter St., Suite 1070 Baltimore, MD 21202
|
| | | | 1,266,546 | | | | | | 3.31% | | | | | | 354,609 | | | | | | 911,937 | | | | | | 2.38% | | |
Dellora Investments Master Fund LP(4)
283 Greenwich Ave., 3rd Floor Greenwich, CT 06830 |
| | | | 212,765 | | | | | | 0.56% | | | | | | 212,765 | | | | | | - | | | | | | * | | |
Laurion Capital Master Fund LTD.(5)
c/o Laurion Capital Management LP 360 Madison Ave., Suite 1900 New York, NY 10017 |
| | | | 709,219 | | | | | | 1.85% | | | | | | 709,219 | | | | | | - | | | | | | * | | |
Lincoln Park Capital Fund, LLC(6)
415 N. LaSalle St., Suite 700B Chicago, IL 60654 |
| | | | 173,374 | | | | | | 0.45% | | | | | | 128,374 | | | | | | 45,000 | | | | | | * | | |
683 Capital Partners, LP(7)
1700 Broadway, Suite 4200 New York, NY 10019 |
| | | | 1,486,456 | | | | | | 3.88% | | | | | | 1,063,829 | | | | | | 422,627 | | | | | | 1.10% | | |
Entities Affiliated with Baker Bros. Advisors LP(8)
860 Washington Street, 3rd Floor New York, NY 10014 |
| | | | 1,948,116 | | | | | | 4.99% | | | | | | 1,523,404 | | | | | | 1,948,116 | | | | | | 4.99% | | |
Gilead Sciences, Inc.(9)
333 Lakeside Dr. Foster City, CA 94404-1147 |
| | | | 5,319,148 | | | | | | 13.90% | | | | | | 5,319,148 | | | | | | - | | | | | | * | | |
| | |
Shares of Common Stock
Beneficially Owned Prior to the Offering |
| |
Maximum Number
of Shares to be Sold Pursuant to this Prospectus(1) |
| |
Shares of Common Stock
Beneficially Owned After the Offering |
| |||||||||||||||||||||
Name and Address of Selling Stockholder(2)
|
| |
Number
|
| |
Percent
(%) |
| |
Number
|
| |
Number
|
| |
Percent
(%) |
| |||||||||||||||
Atlas Diversified Master Fund, Ltd.(10)
444 W. Lake St., 50th Floor Chicago, IL 60606 |
| | | | 3,753,038 | | | | | | 9.81% | | | | | | 3,100,000 | | | | | | 653,038 | | | | | | 1.71% | | |
Samsara BioCapital, LP(11)
628 Middlefield Road Palo Alto, CA 94301 |
| | | | 2,442,352 | | | | | | 6.38% | | | | | | 1,773,049 | | | | | | 669,303 | | | | | | 4.63% | | |
|
SEC Registration Fee
|
| | | $ | 6,636.77 | | |
|
Accounting Fees and Expenses
|
| | | $ | 20,000 | | |
|
Legal Fees and Expenses
|
| | | $ | 50,000 | | |
|
Miscellaneous Fees and Expenses
|
| | | $ | 10,000 | | |
|
Total
|
| | | $ | 86,636.77 | | |
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ DOUGLAS E. ONSI
Douglas E. Onsi
|
| | Chief Executive Officer, President, Chief Financial Officer and Director (Principal Executive Officer and Principal Financial Officer) | | |
May 10, 2024
|
|
|
/s/ CHRISTOPHER K. MIRABELLI
Christopher K. Mirabelli
|
| | Chairman of the Board | | |
May 10, 2024
|
|
|
/s/ JAMES CAVANAUGH
James Cavanaugh
|
| | Director | | |
May 10, 2024
|
|
|
/s/ THOMAS DIETZ
Thomas Dietz
|
| | Director | | |
May 10, 2024
|
|
|
/s/ WILLIAM LI
William Li
|
| | Director | | |
May 10, 2024
|
|
|
/s/ JOSEPH LOSCALZO
Joseph Loscalzo
|
| | Director | | |
May 10, 2024
|
|
|
Signature
|
| |
Title
|
| |
Date
|
|
|
/s/ PATRICIA MARTIN
Patricia Martin
|
| | Director | | |
May 10, 2024
|
|
|
/s/ NISSIM MASHIACH
Nissim Mashiach
|
| | Director | | |
May 10, 2024
|
|
|
/s/ CHRISTIAN RICHARD
Christian Richard
|
| | Director | | |
May 10, 2024
|
|
|
/s/ RICHARD L. SCHILSKY, M.D.
Richard L Schilsky, M.D.
|
| | Director | | |
May 10, 2024
|
|